Human papillomavirus infection in women

Clinics in Dermatology

Volumn 15, Issue 1, 1997, Pages 67-79

  Jablonska, Stefania ^a   Majewski, Slawomir ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BOWENOID PAPULOSIS; CARCINOMA IN SITU; CLINICAL FEATURE; COLLAGEN DISEASE; CONDYLOMA ACUMINATUM; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INFECTION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS TRANSMISSION; VULVA CANCER; WART VIRUS;

EID: 0031081442     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00111-3     Document Type: Article

References (109)

1. 1. Durst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983,80:3812-5.
2. 2. Boshart M, Gissmann L, Ikenberg H, et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
3. 3. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: zur Hausen H, editor. Human pathogenic papillomaviruses. Berlin: Springer Verlag, 1994:131-56.
4. 4. de Villiers E-M. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903.
5. 5. de Villiers W-M. Human pathogenic papillomavirus types: an update. In: zur Hausen H, editor. Human pathogenic papillomaviruses. Current Topics in Microbiology and Immunology. Berlin: Springer-Verlag, 1994: 1-12.
6. 6. Chan S-Y, Bernard H-U, Ong C-K, et al. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evaluation of DNA virus. J Virol 1992;66:5714-25.
7. 7. Bernard HU, Chan SY, Delius H. Evolution of papilloma viruses. In: zur Hausen H, editor. Human pathogenic papillomaviruses, Current Topics in Microbiology and Immunology. Berlin: Springer Verlag, 1994:34-54.
8. 8. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22.
9. 9. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79: 328-37.
10. 10. Beckman AM, Kivial NB, Daling JR, et al. Human papillomavirus type 16 in multifocal neoplasia of the female genital tract. Int J Gynecol Pathol 1988;7:39-47.
11. 11. Pilotti S, Gupta J, Stefano B, et al. Study of multiple human papillomavirus-related lesions of the lower female genital tract by in situ hybridization. Hum Pathol 1989; 20:118-23.
12. 12. Buscema J, Naghashfar Z, Swada E, et al. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol 1988;7:601-6.
13. 13. van Sickle M, Kaufman RH, Adam E, et al. Detection of human papilloma virus DNA before and after development of invasive cancer. Obstet Gynecol 1990;76:540-2.
14. 14. Androphy EJ. Molecular biology of human papillomavirus infection and oncogenesis. J Invest Dermatol 1994; 103:248-56.
15. 15. Sousa R, Dostani N, Yaniv M. Control of papillomavirus gene expression. Biochem Biophys Acta 1990;1032:19-37.
16. 16. Scheffner M, Romanczuk H, Munger K, et al. Functions of human papillomavirus proteins. In: zur Hausen H, editor. Human pathogenic papillomaviruses. Current Topics in Microbiology and Immunology. Berlin: Springer Verlag, 1994:83-99.
17. 17. Boshart M, zur Hausen H. Human papillomavirus in Buschke-Loewenstein tumors: physical state of the DNA and identification of a tandem duplication in the non-coding region of human papillomavirus 6 subtype. J Virol 1986;58:963-6.
18. 18. Rando RF, Sedlacek TV, Hunt J, et al. Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet Gynecol 1986;67(suppl): 70-5.
19. 19. Nevins JR. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-9.
20. 20. Steele C, Cowsert LM, Shillitoe EJ. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res 1993;53:2330-7.
21. 21. Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated lesions. Int J Cancer 1994;57:836-41.
22. 22. Galloway DA, Jenison SA. Characterization of the humoral immune response to genital papillomaviruses. Mol Biol Med 1990;7:59-66.
23. 23. Tindle RW, Frazer IH. Immune response to human papillomavirus and the prospects for human papillomavirus-specific immunisation. In: zur Hausen H, editor. Human pathogenic papillomaviruses. Current Topics in Microbiology and Immunology. Berlin: Springer Verlag, 1994:218-53.
24. 24. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991;352:76-9.
25. 25. Helland A, Borresen AL, Karen J, et al. HLA antigens and cervical carcinoma. Nature 1992;356:23-5.
26. 26. Glew SS, Duggan KM, Cabrera T, et al. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 1992;52:4009-16.
27. 27. Apple RJ, Erlich HA, Klitz W, et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus type specificity. Nature Genet 1994;6:157-62.
28. 28. Kirnbauer R, Hubbert NL, Wheeler CM, et al. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-9.
29. 29. Majewski S, Breitburd F, Orth G, et al. Regulation of MHC class I, class II and ICAM-I expression by cytokines and retinoids in HPV-harboring keratinocyte lines. In: Stanley M, editor. Immunology of human papillomaviruses. New York: Plenum Press, 1994:207-10.
30. 30. Strokus WJ, Dawson JR. Target structures involved in natural killing (NK): characteristics, distribution and candidate molecules. Crit Rev Immunol 1991;10:393-407.
31. 31. Malejczyk J, Malejczyk M, Majewski S, et al. NK-cell activity in patients with HPV16-associated anogenital tumors: defective recognition of HPV16-harboring keratinocytes and restricted unresponsiveness to immuno-stimulatory cytokines. Int J Cancer 1993;54:917-21.
32. 32. Woodworth CD, Lichti U, Simpson S, et al. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res 1992;52: 456-61.
33. 33. Rosl F, Lengert M, Albrecht J, et al. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol 1994;68:2142-50.
34. 34. Malejczyk J, Malejczyk M, Majewski S, et al. Increased tumorigenicity of human papillomavirus type 16-harboring keratinocytes is associated with resistance to endogenous tumor necrosis factor-mediated growth limitation. Int J Cancer 1994;56:593-8.
35. 35. Malejczyk J, Malejczyk M, Breitburd F, et al. Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumor necrosis factor (TNF) receptor. Br J Cancer 1996 (in press).
36. 36. Amortegnin AJ, Mayer MP, McIntyre-Seltman K, et al. Detection of human papillomavirus DNA in cervical probes. Int J Gynecol Pathol 1990;9:306-15.
37. 37. Van de Brule AJ, Snijders PJ, Raaphorst PM, et al. General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions. J Clin Microbiol 1992;30:1716-21.
38. 38. Berkhout RJM, Tieben LM, Smits HI, et al. Nested PCR approach for detection and typing of EV-associated HPV types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
39. 39. de Villiers EM, Gissmann L, zur Hausen H. Molecular cloning of viral DNA from human genital warts. J Virol 1981;40:932-5.
40. 40. Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus type 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983;80:560-3.
41. 41. Gibson PE, Gardner SD, Best SJ. Human papillomavirus types in anogenital warts of children. J Med Virol 1990; 30:142-5.
42. 42. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center. Sex Trans Dis 1993; 20:286-9.
43. 43. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:907-1003.
44. 44. Pao CC, Tsai PL, Chang YL, et al. Possible non-sexual transmission of genital human papillomavirus infections in young women. Eur J Clin Microbiol Infect Dis 1993; 12:221-3.
45. 45. Monsonego J, Zerat L, Catalan F, et al. Genital human papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their male partners. Int STD AIDS 1993;4: 13-20.
46. 46. Hippelainen MJ, Yliskiski M, Syrjanen S, et al. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis 1994;21:76-82.
47. 47. Barrasso R, de Brux J, Croissant O, et al. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Eng J Med 1987;317:916-23.
48. 48. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia: specific clinical features correlate to histological and virological findings. Cancer 1994;74:1762-7.
49. 49. Moyal-Barracco M, Leibowitch M, Orth G. Vestibular papillae of the vulva. Arch Dermatol 1990;126:1594-8.
50. 50. Drake LA and the Committee. Guidelines of care for warts: Human Papillomavirus Committee on Guidelines of Care. J Am Acad Dermatol 1995;32:98-103.
51. 51. Birley HDL, Kupek E, Byrne M, et al. Clinical features and outcome of first presentation anogenital warts in men and women. J Eur Acad Dermatol Venereol 1994;3: 198-205.
52. 52. Semprini AE, Stillo A, Marcozzi S, et al. Treatment with interferon for genital HPV in HIV-positive and HIV-negative women. Eur J Obstet Gynecol 1994;53:135-7.
53. 53. Nuovo GJ, Lastarria DA, Smith S, et al. Human papillomavirus segregation patterns in genital and nongenital warts in prepubertal children and adults. Am J Clin Pathol 1991;95:467-74.
54. 54. Herman-Giddens ME, Gutman LT, Berson NL, et al. Association of coexisting vaginal infections and multiple abuses in female children with genital warts. Sex Transm Dis 1988;54:63-7.
55. 55. Obalek S, Jablonska S, Favre M, et al. Condylomata acuminata in children: frequent association with human papillomaviruses responsible for cutaneous warts. J Am Acad Dermatol 1990;23:205-13.
56. 56. Obalek S, Misiewicz J, Jablonska S, et al. Childhood condyloma acuminatum: association with genital and cutaneous human papillomaviruses. Paediatr Dermatol 1993; 10:101-6.
57. 57. Cohen BA, Honig P, Androphy E. Anogenital warts in children: clinical and virologic evaluation for sexual abuse. Arch Dermatol 1990;126:1575-80.
58. 58. Fairley CK, Gay NJ, Forbes A, et al. Hand-genital transmission of genital warts? An analysis of prevalence data. Epidemiol Infect 1995;115:169-70.
59. 59. Tang CK, Shermet DW, Wood C. Congenital condylomata acuminatum. Am J Obstet Gynecol 1978;131:912-3.
60. 60. Laraque D. Severe anogenital warts in child with human immunodefficiency virus infection. N Eng J Med 1989; 320:1220-1.
61. 61. Armbruster-Moraes E, Ioshimoto LM, Leao E, et al. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 1994;54:152-8.
62. 62. Roman A, Fife K. Human papillomavirus DNA associated with foreskins of normal newborns. J Infect Dis 1986;153:855-60.
63. 63. Jenison SA, Yu X, Valentine JM, et al. Evidence of prevalent genital type human papillomavirus infections in adults and children. J Infect Dis 1990;162:60-9.
64. 64. Pakarian FB, Kaye JM, Cason J, et al. Cancer-associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynecol 1994;101:514-7.
65. 65. Sedlacek TV, Lindheim S, Eder C, et al. Mechanism for human papillomavirus transmission at birth. Am J Obstet Gynecol 1989;161:55-9.
66. 66. Smith EM, Jahnson SR, Cripe TP, et al. Perinatal transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Laryngol 1991;100:479-83.
67. 67. Simson M, Khan T, Schneider A, et al. Laryngeal carcinoma in a 12-year-old child: association with human papillomavirus types 18 and 33. Arch Otolaryngol Head Neck Surg 1994;120:277-82.
68. 68. Shah K, Kashima H, Polk BF, et al. Rarity of cesarean delivery in cases of juvenile onset respiratory papillomatosis. Obstet Gynecol 1986;68:795-9.
69. 69. Morelli AE, Belardi G, Dipaola GR, et al. Cellular subsets and epithelial ICAM-1 and HLA-DR expression in human papillomavirus infection of the vulva. Acta Dermatol Venereol (Stokh) 1994;74:45-50.
70. 70. Obalek S, Jablonska S, Orth G. HPV-associated intraepithelial neoplasia of external genitalia. Clin Dermatol 1985;3:104-13.
71. 71. Obalek S, Jablonska S, Favre M, et al. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol 1986;14:433-44.
72. 72. Bergeron Ch, Naghashfar Z, Canaan C, et al. Human papillomavirus type 16 in intraepithelial neoplasia (bowenoid papulosis) and coexistent invasive carcinoma of the vulva. Int J Gynecol Pathol 1987;6:1-11.
73. 73. Kato T, Saijyo S, Hatchome N, et al. Detection of human papillomavirus type 16 in bowenoid papulosis and invasive carcinoma occurring in the same patient with a history of cervical carcinoma. Arch Dermatol 1988;124: 851-2.
74. 74. Della Torre G, Donghi R, Longoni A, et al. HPV DNA in intraepithelial neoplasia and carcinoma of vulva and penis. Diagn Mol Pathol 1992;1:25-30.
75. 75. Gross GG, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis. Arch Dermatol 1985;121:858-63.
76. 76. Rudlinger R, Grob R, Yu YX, et al. Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus-35-positive verruca with bowenoid dysplasia of the periungual area. Arch Dermatol 1989;125:655-9.
77. 77. Beaudenon S, Kremsdorf D, Obalek S, et al. Plurality of genital papillomavirus: characterization of two new types with distinct biological properties. Virology 1987; 161:374-84.
78. 78. Fevre M, Kremsdorf D, Jablonska S, et al. Two new human papillomavirus types (HPV54 and 55) characterized from genital tumours illustrate the plurality of genital HPVs. Int J Cancer 1990;45:40-6.
79. 79. Buscema J, Woodruff JD. Progressive histobiologic alterations in the development of vulvar cancer. Report of five cases. Am J Obstet Gynecol 1980;138:146-50.
80. 80. Rudlinger R. Bowenoid papulosis of the male and female genital tracts: risk of cervical neoplasia. J Am Acad Dermatol 1987;16:625-7.
81. 81. Sherman KJ, Daling JR, Chu J, et al. Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiology 1991;2:257-62.
82. 82. Sturgeon SR, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer: incidence, trends (1973 to 1987). Am J Obstet Gynecol 1992;166:1482-5.
83. 83. Bronstein J, Kaufman RH, Adam E, et al. Multicentric intraepithelial neoplasia involving the vulva. Clinical features and association with human papillomavirus and herpes simplex virus. Cancer 1988;62:1601-4.
84. 84. Majewski S, Skopiñska M, Bollag W, et al. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994;344:1510-1.
85. 85. Majewski S, Szmurlo A, Marczak M, et al. Synergistic effect of retinoids and interferon alpha on tumor-induced angigenesis: antiangiogenic effect on HPV-harboring tumor-cell lines. Int J Cancer 1994;57:81-5.
86. 86. Bollag W, Majewski S, Jablonska S. Biological interactions of retinoids with cytokines and vitamin D analogs as a basis for cancer combination and chemotherapy. In: Livrea MA, Vidali G, editors. Retinoids: from basic science to clinical applications. Basel: Birkhauser Verlag, 1994:267-80.
87. 87. Schwartz RA. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 1995;32:1-21.
88. 88. Grassegger A, Hopfl R, Hussl H, et al. Buschke-Loewenstein tumor infiltrating pelvic organs. Br J Dermatol 1994; 130:221-5.
89. 89. Jablonska S, Obalek S, Orth G, et al. Tumeur geante de Buschke-Loewenstein a HPV-6 avec metastases dans la paroi abdominale. Ann Dermatol Venereol 1988;115: 1201-2.
90. 90. Valente PT, Hurt MA, Jelen J. Human papillomavirus-associated vulvar verrucous carcinoma in a 20-year-old with an intact hymen: a case report. J Report Med 1991; 36:213-6.
91. 91. Barbosa MS, Wass WC, Lowy DR, et al. In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol 1991;65:292-8.
92. 92. Tsambaos D, Monastirli A, Kapranos N. Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumor. Acta Dermatol Venerol (Stockh) 1994;74:457-9.
93. 93. Risse L, Negrier P, Dang PM, et al. Treatment of verrucous carcinoma with recombinant alfa-interferon. Dermatology 1995;190:142-4.
94. 94. Palefsky JM, Holly EA, Gonzales J, et al. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 1991;51:1014-9.
95. 95. Scholefield JH, Hickson WGE, Smith JHF, et al. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;240(8830):1271-3.
96. 96. Shroyer KR, Brookes CG, Markham NE, et al. Detection of human papillomavirus in anorectal squamous cell carcinoma: correlation with basaloid pattern of differentiation. Am J Clin Pathol 1995;104:299-305.
97. 97. Jablonska S. Epidermodysplasia verruciformis. In: Friedman RJ, Rigel D, Kopf A, et al., editors. Cancer of the skin. Philadelphia: WB Saunders Company, 1991:101-113.
98. 98. Coppleson M. Colposcopic features of papillomaviral infection and premalignancy in the female lower genital tract. Human papillomavirus infection. Dermatol Clin 1991;9:251-66.
99. 99. Kulski JK, Demeter T, Rokoczy R, et al. Human papillomavirus coinfections of the vulva and uterine cervix. J Med Virol 1989;27:244-54.
100. 100. Strand A, Rylander E, Wilander E, et al. HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV. Acta Derm Venereol (Stockh) 1995;75:312-6.
101. 101. Schrager LK, Friedland GH, Maude KM, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J AIDS 1989; 2:570-5.
102. 102. Smith EM, Johnson SR, Jiang D, et al. The association between pregnancy and human papilloma virus prevalence. Cancer Detec Prev 1991;15:397-402.
103. 103. Kemp EA, Hakenewerth AM, Laurent SL, et al. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649-56.
104. 104. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987;40:198-201.
105. 105. Pater A, Bayatpour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 1990;162: 1099-103.
106. 106. Vandanvelde CH, Van Beers D. Oral contraceptives and papillomavirus persistence in normal cervix. Lancet 1992;339:1294.
107. 107. Liu T, Soong S-J, Alvarez RD, et al. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression. Cancer Epidemiol Biomarkers 1995;4:373-80.
108. 108. Butterworth CE, Hotch K, Macluso M, et al. Folate deficiency and cervical dysplasia. JAMA 1992;267:528-33.
109. 109. Christensen ND, Hopfl R, Di Angelo SL, et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing antibodies. J Gen Virol 1994;75:2271-6.